A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of CJ-12420 in Healthy Male Volunteers

Next Previous
Trial Profile

A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of CJ-12420 in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Tegoprazan (Primary)
  • Indications Erosive oesophagitis
  • Focus Pharmacokinetics
  • Sponsors CJ HealthCare

    • Most Recent Events

    • 19 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top